moxtenz 0,3 mg
farmak international sp. z o.o., poľsko - moxonidín - 58 - hypotensiva
moxtenz 0,2 mg
farmak international sp. z o.o., poľsko - moxonidín - 58 - hypotensiva
maymetsi 50 mg/1000 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
maymetsi 50 mg/850 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
sitagliptin/metformin krka 50 mg/850 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
sitagavia met 50 mg/1000 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
sitagavia met 50 mg/850 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
furosemid medreg
medreg s.r.o., Česká republika - furosemid - 50 - diuretica
qaialdo
nova laboratories ireland limited - spironolaktón - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 a 5.
zypsilan 20 mg
krka, d.d., novo mesto, slovinsko - ziprazidón - 68 - antipsychotica (neuroleptica)